13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1152 20 1044 80 974 165 1004
ERLYTX 88 1 52 6 73 17 103
GI 171 4 209 13 158 31 189
GU 347 8 417 43 524 74 450
LEUK 159 3 157 17 207 36 219
LUNG 205 2 104 18 219 38 231
LYMPH 421 11 574 35 426 77 469
MELAN 66 0 0 0 0 0 0
MMYEL 117 2 104 8 97 22 134
MULT 47 1 52 4 49 9 55
OTHER 56 2 104 5 61 8 49
SXQOL 3 1 52 1 12 3 18
Total 2832 55 2869 230 2800 480 2921

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 179 7 365 25 304 40 244
ERLYTX 5 0 0 1 12 1 6
GU 4 0 0 0 0 0 0
LEUK 619 11 574 39 475 94 572
LUNG 377 8 417 25 304 56 341
OTHER 12 0 0 1 12 1 6
PEOLC 100 1 52 3 37 6 37
PREV 251 3 157 20 244 46 280
SXQOL 628 9 470 35 426 81 493
Total 2176 40 2087 150 1826 326 1985

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 1152 20 1044 80 974 165 1004
CCD 179 7 365 25 304 40 244
ERLYTX 93 1 52 7 85 18 110
GI 171 4 209 13 158 31 189
GU 351 8 417 43 524 74 450
LEUK 778 14 730 56 682 130 791
LUNG 582 10 522 43 524 94 572
LYMPH 421 11 574 35 426 77 469
MELAN 66 0 0 0 0 0 0
MMYEL 117 2 104 8 97 22 134
MULT 47 1 52 4 49 9 55
OTHER 68 2 104 6 73 9 55
PEOLC 100 1 52 3 37 6 37
PREV 251 3 157 20 244 46 280
SXQOL 631 10 522 36 438 84 511
Total 5008 95 4956 380 4627 806 4907

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 716 13 678 48 584 93 566
ERLYTX 54 1 52 4 49 12 73
GI 127 3 157 10 122 21 128
GU 267 5 261 30 365 53 323
LEUK 99 2 104 12 146 22 134
LUNG 126 1 52 8 97 23 140
LYMPH 275 6 313 21 256 52 317
MELAN 46 0 0 0 0 0 0
MMYEL 68 1 52 4 49 10 61
MULT 18 0 0 2 24 4 24
OTHER 55 1 52 4 49 7 43
SXQOL 3 1 52 1 12 3 18
Total 1854 34 1773 144 1753 300 1827

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
CCD 137 4 209 16 195 26 158
ERLYTX 5 0 0 1 12 1 6
GU 4 0 0 0 0 0 0
LEUK 268 7 365 15 183 44 268
LUNG 229 5 261 17 207 34 207
OTHER 12 0 0 1 12 1 6
PEOLC 76 1 52 3 37 6 37
PREV 251 3 157 20 244 46 280
SXQOL 457 7 365 24 292 54 329
Total 1440 28 1461 98 1194 213 1297

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
  1 1 52 1 12 1 6
BREAST 891 16 835 59 718 121 737
CCD 161 2 104 12 146 22 134
ERLYTX 59 1 52 5 61 13 79
GI 132 1 52 12 146 23 140
GU 303 9 470 30 365 58 353
LEUK 368 9 470 27 329 66 402
LUNG 377 8 417 28 341 60 365
LYMPH 275 6 313 21 256 52 317
MELAN 46 0 0 0 0 0 0
MMYEL 68 1 52 4 49 10 61
MULT 41 1 52 1 12 6 37
OTHER 167 1 52 5 61 8 49
PEOLC 75 3 157 5 61 9 55
PREV 251 3 157 20 244 46 280
SXQOL 460 8 417 25 304 57 347
Total 3675 70 3652 255 3105 552 3362

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 971 18 939 71 864 151 919
ERLYTX 83 1 52 6 73 17 103
GI 101 1 52 8 97 21 128
GU 244 6 313 32 390 56 341
LEUK 126 3 157 14 170 32 195
LUNG 178 2 104 17 207 35 213
LYMPH 353 11 574 28 341 65 396
MMYEL 104 2 104 8 97 20 122
MULT 47 1 52 4 49 9 55
Total 2207 45 2347 188 2288 406 2472

13-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1942 33 1722 137 1668 299 1820
AFFIL 142 1 52 8 97 22 134
CCOP/NCORP 1210 28 1461 97 1181 192 1169
Non-SWOG 1711 30 1565 135 1644 290 1765
Total 5005 92 4800 377 4590 803 4888

13-JUL-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT 1 Y 06-JUL-26

13-JUL-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 1 E 30-JUN-26
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 2 E 30-JUN-26
OTHER NRGBN013 Brain, Intact Metas, SRS vs FSRS 1 E 22-JUN-26
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 T 09-JUL-26

13-JUL-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 15
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
LUNG LUNGMAP NSCLC, Adv, Master 2 9
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 9
LUNG LUNGMAP NSCLC, Adv, Master 1 8
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 8
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 7
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 3 5
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 4
CCD S2417CD Colrec Surv, Follow-up w/ CTAC site 1 4
CCD EAQ222CD CostCOM, Cancer Patients, OOP Cost Com 0 3
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 3
GI NRGGI008 Colon, Stg III, Adj Chemo 2 3
PEOLC S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 1 3
MULT S2101 Melan or HNSCC, Adv, Cabo + Nivo 1 3
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 3